Azitra, Inc. Diluted Shares Outstanding (Weighted Average)
Azitra, Inc. (AZTR) reported Diluted Shares Outstanding (Weighted Average) of 19.30 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-12
- Azitra, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 19.30M shares, a 689.61% increase year-over-year.
- Azitra, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 15.52M shares, a 684.66% increase year-over-year.
- Azitra, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 10.93M shares, a 851.19% increase year-over-year.
- Azitra, Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 4.12M shares, a 365.88% increase year-over-year.
- Azitra, Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 4.87M shares, a 753.27% increase from fiscal 2024.
- Azitra, Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 571.16K shares, a 148.48% increase from fiscal 2023.
- Azitra, Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 229.87K shares, a 78.22% decline from fiscal 2022.
- Azitra, Inc. weighted average number of shares outstanding, diluted for fiscal 2022 was 1.06M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 19.30M shares 10-Q · filed 2026-08-12 | 17.42M shares 10-Q · filed 2026-08-12 | 15.25M shares derived: average of 3 quarters · filed 2026-08-12 | 12.47M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2026-03-31 | 15.52M shares 10-Q · filed 2026-05-13 | 13.22M shares derived: average of 2 quarters · filed 2026-05-13 | 10.19M shares derived: average of 3 quarters · filed 2026-05-13 | 8.25M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-12-31 | 10.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 7.52M shares derived: average of 2 quarters · filed 2026-02-27 | 5.83M shares derived: average of 3 quarters · filed 2026-08-12 | 4.87M shares 10-K · filed 2026-02-27 | ||||
| 2025-09-30 | 4.12M shares 10-Q · filed 2025-11-12 | 3.28M shares derived: average of 2 quarters · filed 2026-08-12 | 2.85M shares 10-Q · filed 2025-11-12 | 2.42M shares derived: average of 4 quarters · filed 2026-08-12 | ||||
| 2025-06-30 | 2.44M shares 10-Q · filed 2026-08-12 | 16.28M shares 10-Q · filed 2025-08-11 | 2.21M shares 10-Q · filed 2026-08-12 | 14.73M shares 10-Q · filed 2025-08-11 | 1.86M shares derived: average of 3 quarters · filed 2026-08-12 | 1.61M shares derived: average of 4 quarters · filed 2026-08-12 | ||
| 2025-03-31 | 1.98M shares 10-Q · filed 2026-05-13 | 13.17M shares 10-Q · filed 2025-05-13 | 1.56M shares derived: average of 2 quarters · filed 2026-05-13 | 1.34M shares derived: average of 3 quarters · filed 2026-05-13 | 1.24M shares derived: average of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | 1.15M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | 1.02M shares derived: average of 2 quarters · filed 2026-02-27 | 997.73K shares derived: average of 3 quarters · filed 2026-02-27 | 571.16K shares 10-K · filed 2026-02-27 | 3.78M shares 10-K · filed 2025-02-24 | |||
| 2024-09-30 | 883.87K shares 10-Q · filed 2025-11-12 | 5.81M shares 10-Q · filed 2024-11-12 | 922.01K shares derived: average of 2 quarters · filed 2025-11-12 | 378.49K shares 10-Q · filed 2025-11-12 | 2.49M shares 10-Q · filed 2024-11-12 | 731.06K shares derived: average of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | 960.15K shares 10-Q · filed 2025-08-11 | 816.45K shares 10-Q · filed 2025-08-11 | 680.13K shares derived: average of 3 quarters · filed 2025-08-11 | 610.91K shares derived: average of 4 quarters · filed 2025-08-11 | ||||
| 2024-03-31 | 678.88K shares 10-Q · filed 2025-05-13 | 20.18M shares 10-Q · filed 2024-05-09 | 540.12K shares derived: average of 2 quarters · filed 2025-05-13 | 494.50K shares derived: average of 3 quarters · filed 2025-05-13 | 388.78K shares derived: average of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | 401.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-24 | 402.30K shares derived: average of 2 quarters · filed 2025-02-24 | 292.08K shares derived: average of 3 quarters · filed 2025-02-24 | 229.87K shares 10-K · filed 2025-02-24 | 6.92M shares 10-K · filed 2024-03-15 | |||
| 2023-09-30 | 403.25K shares 10-Q · filed 2024-11-12 | 12.10M shares 10-Q · filed 2023-11-14 | 237.44K shares derived: average of 2 quarters · filed 2024-11-12 | 172.70K shares 10-Q · filed 2024-11-12 | 5.18M shares 10-Q · filed 2023-11-14 | 646.45K shares derived: average of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | 71.62K shares 10-Q · filed 2024-08-12 | 2.15M shares 10-Q · filed 2023-08-14 | 53.50K shares 10-Q · filed 2024-08-12 | 1.60M shares 10-Q · filed 2023-08-14 | 727.51K shares derived: average of 3 quarters · filed 2024-08-12 | 809.50K shares derived: average of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | 1.06M shares 10-Q · filed 2024-05-09 | 1.06M shares derived: average of 2 quarters · filed 2024-05-09 | 1.06M shares derived: average of 3 quarters · filed 2024-05-09 | 1.06M shares derived: average of 4 quarters · filed 2024-05-09 | ||||
| 2022-12-31 | 1.06M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 1.06M shares derived: average of 2 quarters · filed 2024-03-15 | 1.06M shares derived: average of 3 quarters · filed 2024-03-15 | 1.06M shares 10-K · filed 2024-03-15 | ||||
| 2022-09-30 | 1.06M shares 10-Q · filed 2023-11-14 | 1.06M shares derived: average of 2 quarters · filed 2023-11-14 | 1.06M shares 10-Q · filed 2023-11-14 | |||||
| 2022-06-30 | 1.06M shares 10-Q · filed 2023-08-14 | 1.06M shares 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |